Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin-α1 for Cancer-Related Fatigue
NCT02127268Phase 3Unknown
- Start
- Apr 2014
- Primary completion
- Apr 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of thymosin alpha 1 in cancer-related fatigue (CRF). Status: unknown.
02
Drugs
thymosin alpha 1
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT02127268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127268.